211 related articles for article (PubMed ID: 27306073)
1. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
Kochhar G; Singh T; Dust H; Lopez R; McCullough AJ; Liu X; Fung J; Shen B
Inflamm Bowel Dis; 2016 Jul; 22(7):1670-8. PubMed ID: 27306073
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control study.
Mogl MT; Baumgart DC; Fischer A; Pratschke J; Pascher A
Z Gastroenterol; 2018 Feb; 56(2):117-127. PubMed ID: 29212098
[TBL] [Abstract][Full Text] [Related]
3. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
[TBL] [Abstract][Full Text] [Related]
4. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.
Ribaldone DG; Imperatore N; Le Grazie M; Furfaro F; Balestrieri P; De Blasio F; Fagoonee S; Mosso E; Boano V; Reggio D; Sarli E; Castiglione F; Milla M; Vecchi M; Saracco GM; Salizzoni M; Romagnoli R; Fiorino G; Astegiano M;
Dig Liver Dis; 2021 Jun; 53(6):712-716. PubMed ID: 32972831
[TBL] [Abstract][Full Text] [Related]
8. Clinical course and management of inflammatory bowel disease after liver transplantation.
Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease following solid organ transplantation.
Hampton DD; Poleski MH; Onken JE
Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation.
Miki C; Harrison JD; Gunson BK; Buckels JA; McMaster P; Mayer AD
Br J Surg; 1995 Aug; 82(8):1114-7. PubMed ID: 7648169
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
[TBL] [Abstract][Full Text] [Related]
12. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
[TBL] [Abstract][Full Text] [Related]
13. De novo inflammatory bowel disease after pediatric kidney or liver transplant.
Fernandes MA; Braun HJ; Evason K; Rhee S; Perito ER
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27862714
[TBL] [Abstract][Full Text] [Related]
14. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
[TBL] [Abstract][Full Text] [Related]
15. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states.
Saigal S; Norris S; Srinivasan P; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2001 Jan; 7(1):11-5. PubMed ID: 11150415
[TBL] [Abstract][Full Text] [Related]
16. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
[TBL] [Abstract][Full Text] [Related]
18. De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.
Dehghani SM; Eshraghian A; Bahador A; Kakaei F; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2009 Sep; 7(3):145-8. PubMed ID: 19715523
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in liver transplantation.
McDiarmid SV
Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
